Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib
Clinical trial NCT01487265 · COMPLETED
Trial details
- NCT number
- NCT01487265
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-05-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.